BioNTech SE (BNTX)
94.09
-2.86
(-2.95%)
USD |
NASDAQ |
May 28, 16:00
93.20
-0.89
(-0.95%)
After-Hours: 05:39
BioNTech Profit Margin (Quarterly): -168.0% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -168.0% |
December 31, 2023 | 30.96% |
September 30, 2023 | 17.94% |
June 30, 2023 | -113.5% |
March 31, 2023 | 39.33% |
December 31, 2022 | 53.26% |
September 30, 2022 | 51.57% |
June 30, 2022 | 52.31% |
March 31, 2022 | 58.02% |
December 31, 2021 | 57.23% |
September 30, 2021 | 52.75% |
June 30, 2021 | 52.50% |
Date | Value |
---|---|
March 31, 2021 | 55.07% |
December 31, 2020 | |
September 30, 2020 | -311.1% |
June 30, 2020 | -211.8% |
March 31, 2020 | -192.8% |
December 31, 2019 | -208.1% |
September 30, 2019 | -105.0% |
June 30, 2019 | -194.2% |
March 31, 2019 | -155.4% |
December 31, 2018 | -2.12% |
September 30, 2018 | -114.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-311.1%
Minimum
Sep 2020
58.02%
Maximum
Mar 2022
-51.77%
Average
30.96%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
GSK PLC | 14.21% |
Novavax Inc | -157.2% |
Pfizer Inc | 20.94% |
Moderna Inc | -703.6% |
Autolus Therapeutics PLC | -522.1% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 0.54% |
Return on Assets | 0.49% |
Return on Invested Capital | 0.54% |
Gross Profit Margin (Quarterly) | 68.50% |
Operating Margin (Quarterly) | -270.4% |
Return on Net Operating Assets | 1.95% |